Sanara MedTech
SMTI
21 hedge funds and large institutions have $9.72M invested in Sanara MedTech in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 8 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
5% more funds holding
Funds holding: 20 → 21 (+1)
3.98% less ownership
Funds ownership: 7.51% → 3.53% (-4%)
44% less capital invested
Capital invested by funds: $17.2M → $9.72M (-$7.49M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRC
North Run Capital
Boston,
Massachusetts
|
+$820K |
| 2 |
SMG
Smart Money Group
Eastland,
Texas
|
+$292K |
| 3 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$262K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$255K |
| 5 |
BlackRock
New York
|
+$240K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$7.01M |
| 2 |
MS
Maven Securities
St Helier,
Jersey
|
-$2.03M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.37M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$433K |
| 5 |
Millennium Management
New York
|
-$419K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| – | -$45K | -1,435 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | -$12K | -393 | Closed |
|
28
Bank of America
Charlotte,
North Carolina
| – | +$292 | +10 | New |
|
SMTI Hedge Fund Activity: Q2 2021 in Review
21 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q2 2021, worth a combined $9.72M — down 44% from $17.2M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new SMTI positions and 8 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.
The largest buyer was North Run Capital, opening a new position worth an estimated $820K. The largest seller was Opaleye Management, exiting entirely with an estimated $7.01M sold.
- 21 institutional investors held Sanara MedTech (SMTI) as of Q2 2021, up from 20 in Q1 2021.
- Funds reported $9.72M of Sanara MedTech stock for Q2 2021, down 44% quarter-over-quarter.
- 9 funds opened new Sanara MedTech positions in Q2 2021 and 8 closed out, a net change of +1 holder.
- The largest Sanara MedTech buyer in Q2 2021 was North Run Capital, an estimated $820K added.
- The largest Sanara MedTech seller in Q2 2021 was Opaleye Management, an estimated $7.01M sold.
Based on aggregated 13F filings for Q2 2021.